Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Syros Pharmaceuticals (NQ: SYRS )

2.690 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.690
Bid (Size) 2.660 (1)
Ask (Size) 2.720 (2)
Prev. Close 2.690
Today's Range 2.690 - 2.690
52wk Range 2.600 - 15.49
Shares Outstanding 61,947,150
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Syros Announces Clinical Updates and 2022 Goals to Support its Advancement to a Fully Integrated Biopharmaceutical Company
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today provided an update on its clinical development programs and outlined its... 
From Business Wire News Releases
Syros to Participate in Upcoming Investor Conferences
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will... 
From Business Wire News Releases

Performance

YTD
-29.21%
-29.21%
1 Month
-23.58%
-23.58%
3 Month
-38.30%
-38.30%
6 Month
-44.76%
-44.76%
1 Year
-82.01%
-82.01%

More News

Read More
Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
From Business Wire News Releases
Syros to Report Third Quarter 2021 Financial Results on Friday, November 5, 2021
From Business Wire News Releases
Syros Reports Inducement Grant to Chief Financial Officer under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
How The Pieces Add Up: IEIH Headed For $42
Tags ETFs
From ETF Channel
Syros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags Top Gainers CPIX Markets
From Benzinga
Syros Announces First Patient in Dose Confirmation Study of SY-2101, a Novel Oral Form of Arsenic Trioxide, in Acute Promyelocytic Leukemia
From Business Wire News Releases
Syros Reports Inducement Grant to Chief Commercial Officer under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Syros Announces Appointment of Conley Chee as Chief Commercial Officer
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.